Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
June, 2026
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
Anas Younes/OncoDaily
Dec 6, 2025, 15:02

Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25

Anas Younes, SVP, CMO and Global Head of Hematology, Oncology R and D at AstraZeneca, shared on LinkedIn:

”Every year, ASH25 is a moment to recognize the progress we’re making in hematology and celebrate the breakthroughs that help to transform care, from next-generation T-cell engagers to advances in cell therapy.

At AstraZeneca, we’re advancing a diverse range of innovations and expanding access to next-generation therapies that aim to deliver deeper, more durable responses while easing the daily burden of treatment for people living with blood cancer.

It’s great to continue these conversations throughout ASH and explore how these breakthroughs are potentially shaping a more hopeful future for blood cancer care.

Read my latest article to learn more.”

Anas Younes on AstraZeneca's Aims in Blood Cancer to Be Presented at ASH25

All from ASH25 featured in Hemostasis Today.

Anas Younes ASH25 AstraZeneca Blood Cancer Cell Therapy Health Hematology Hemostasis Hemostasis Today Medicine thrombosis
NewsFeed